| AIV |
APARTMENT INVESTMENT & MANAGEMENT CO |
Class A Common Stock, no par value (the "Common Stock") |
8.6% |
$73,347,067 |
|
12,347,991 |
|
Madison Avenue International LP |
26 Feb 2026 |
| MDRX |
Veradigm Inc. |
Common Stock, par value $0.01 per share (the "Common Stock") |
6.6% |
$34,185,621 |
|
7,167,999 |
|
Madison Avenue International LP |
22 Jan 2026 |
| SLRN |
ACELYRIN, Inc. |
Common Stock |
5.1% |
$12,468,687 |
|
5,089,260 |
|
Madison Avenue Partners, LP |
29 Apr 2025 |
| INDV |
Indivior Pharmaceuticals, Inc. |
Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") |
5% |
$213,537,068 |
-$39,360,134 |
6,280,502 |
-16% |
Madison Avenue International LP |
31 Dec 2025 |
| MAGN |
Magnera Corporation |
Common Stock, $0.01 par value per share (the "Common Stock") |
5% |
$26,959,026 |
-$15,921,708 |
1,780,649 |
-37% |
Madison Avenue International LP |
31 Dec 2025 |
| WLY |
John Wiley & Sons, Inc. |
Class A Common Stock, par value $1.00 per share (the "Common Stock") |
5% |
$98,427,963 |
|
2,229,904 |
|
Madison Avenue Partners, LP |
31 Dec 2024 |
| OVID |
Ovid Therapeutics Inc. |
Common Stock, par value $0.001 per share (the "Common Stock") |
4% |
$969,800 |
|
2,852,352 |
|
Madison Avenue Partners, LP |
31 Dec 2024 |
| KROS |
Keros Therapeutics, Inc. |
Common Stock, $0.0001 par value per share (the "Common Stock") |
2.7% |
$16,062,286 |
-$34,918,552 |
823,707 |
-68% |
Madison Avenue International LP |
31 Dec 2025 |
| CRGX |
CARGO Therapeutics, Inc. |
Common stock, par value $0.001 per share (the "Common Stock") |
0% |
$0 |
-$18,745,508 |
0 |
-100% |
Madison Avenue Partners, LP |
30 Sep 2025 |
| SAGE |
Sage Therapeutics, Inc. |
Common Stock, par value $0.0001 per share (the "Common Stock") |
0% |
$0 |
-$124,440,060 |
0 |
-100% |
Madison Avenue Partners, LP |
30 Sep 2025 |